Merck Foundation and First Ladies of Africa mark World Cancer Day 2025: 194 Oncology Scholarships Provided Across 32 African Countries ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... then I doubt we'll see any rate hikes in the first half of the year.” He then posed the question: if investors ...

Merck & Co. said Tuesday it is pausing shipments to ... sales in China emerged six months ago when Merck announced the first initial drop in sales. At the time, Merck executives said a number ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that ... New negotiated prices for that first round of drugs go into effect ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the ...

On Tuesday (February 4), Amgen (NASDAQ:AMGN), Merck (NYSE:MRK ... increase in product sales was primarily by the pharmaceutical company's strong performance in oncology and immunology therapies ...

My most recent article was written on June 10, titled “Dividends And Innovation: Why Merck Is A ... pause to China. At first sight, the numbers weren't half bad, as the company generated 7% ...